|
Big Tax-Exempt Hospitals Are Turning Patient Discounts Into Corporate Profits
Friday, Feb 13, 2026 - Posted by Advertising Department [The following is a paid advertisement.] Across Illinois, large hospital systems and corporate PBMs are profiting from a program meant to help patients. The 340B program allows hospitals to buy medications at steep discounts, but those savings aren’t passed on to patients in need. Instead, large hospitals charge patients full price for 340B-discounted drugs, keep the difference, and share the cash with for-profit chain pharmacies and PBMs.
|
|
Keep Insurance Affordable
Friday, Feb 13, 2026 - Posted by Advertising Department [The following is a paid advertisement.] The Illinois General Assembly is considering legislation (HB 3799, SA 2 &3) that could make homeowners insurance unaffordable for many Illinoisans. The proposal would destabilize a healthy, competitive market, creating a regulatory framework that is more extreme than what exists in any other state. This will increase premiums and reduce competition. Our robust insurance market has kept homeowners’ rates middle-of-the-pack nationally, even though Illinois has more hail damage claims than any other state except Texas. To protect affordability and consumer choice, lawmakers should VOTE NO. For more information, visit www.KeepInsuranceAffordable.org
|
|
340B Invests In Patient Care – Support HB 2371 To Support Lifesaving Healthcare
Friday, Feb 13, 2026 - Posted by Rich Miller Sinai Chicago, one of Illinois’ largest safety net providers, can invest in services like specialty clinics and medication management because of drug cost savings from the federal 340B program. Yet pharmaceutical manufacturers have been restricting provider participation in the program, undermining the program’s purpose and restricting patient access to drugs and healthcare services. Dr. Wesley Gibbert with Erie Family Health Centers said helping low-income patients access affordable medications where they live is one of 340B’s most important roles. Two of his patients, a mother and son who both have diabetes, travel an hour from their Mundelein home to Chicago, and an hour back, because drugmakers arbitrarily restricted the FQHC to dispensing prescriptions at a single Chicago pharmacy. HB 2371 will prevent drugmakers from dictating which pharmacies healthcare providers can work with or forcing them into arrangements that undermine provider operations. Hospitals and FQHCs are urging House legislators to protect 340B. At a Feb. 1 rally, Sinai Chicago President and CEO Dr. Ngozi Ezike said, “We are standing up for those who are too often left behind, who are too often forgotten about. It’s time for our legislators to vote YES for HB 2371.” Patients across Illinois are counting on you. Learn more.
|
| PREVIOUS POSTS » |







